ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
TissueGene changes name to Kolon TissueGene, Inc.
March 21, 2018By adding the name "Kolon," the new corporate identity recognizes the patient but committed support and effort by its parent company and major shareholder, the Kolon Group. -
TissueGene awarded $750,000 Maryland Stem Cell Grant for Invossa clinical study
July 04, 2017The grant award will be used by TissueGene to fund a component of a clinical study at a Maryland location for its US Phase III clinical trial for Invossa.
Pharma Sources Insight January 2025
